| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
25,004 |
23,303 |
$6.76M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
34,479 |
32,516 |
$6.06M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
7,869 |
7,226 |
$2.98M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
10,348 |
9,810 |
$1.01M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
13,856 |
12,874 |
$399K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
10,512 |
9,908 |
$261K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
3,000 |
1,456 |
$183K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
37,976 |
34,918 |
$169K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
10,503 |
9,081 |
$126K |
| 80053 |
Comprehensive metabolic panel |
31,199 |
27,079 |
$109K |
| 71045 |
Radiologic examination, chest; single view |
8,334 |
7,708 |
$93K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
19,504 |
17,280 |
$72K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
7,248 |
6,757 |
$70K |
| 87276 |
|
12,539 |
11,890 |
$67K |
| 71046 |
Radiologic examination, chest; 2 views |
4,852 |
4,569 |
$64K |
| 84484 |
|
5,094 |
4,473 |
$61K |
| 87275 |
|
12,542 |
11,893 |
$49K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,663 |
1,499 |
$44K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,052 |
985 |
$42K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
7,594 |
7,089 |
$41K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
9,203 |
8,424 |
$41K |
| 83690 |
|
8,730 |
8,190 |
$35K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,255 |
5,074 |
$31K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
8,979 |
8,324 |
$30K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
52 |
52 |
$30K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
698 |
635 |
$21K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
202 |
188 |
$18K |
| 87081 |
|
4,902 |
4,726 |
$17K |
| 70450 |
Computed tomography, head or brain; without contrast material |
794 |
739 |
$14K |
| 84703 |
|
3,110 |
2,953 |
$14K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
169 |
162 |
$13K |
| 81001 |
|
12,928 |
12,070 |
$11K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
188 |
187 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,205 |
1,140 |
$10K |
| 94726 |
|
358 |
339 |
$9K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
10,717 |
9,692 |
$8K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
129 |
120 |
$7K |
| 94729 |
|
915 |
868 |
$6K |
| 81003 |
|
5,673 |
5,343 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,109 |
2,897 |
$5K |
| 87210 |
|
701 |
627 |
$4K |
| 83605 |
|
769 |
696 |
$4K |
| 77336 |
|
63 |
29 |
$4K |
| 85379 |
|
486 |
447 |
$4K |
| 87186 |
|
562 |
523 |
$3K |
| 81025 |
|
1,111 |
1,054 |
$3K |
| 87147 |
|
230 |
201 |
$3K |
| 82728 |
|
724 |
650 |
$3K |
| 84466 |
|
721 |
647 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,085 |
1,842 |
$2K |
| 94060 |
|
42 |
42 |
$2K |
| 87807 |
|
423 |
402 |
$2K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
15 |
13 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
243 |
225 |
$1K |
| 83540 |
|
727 |
650 |
$1K |
| 83735 |
|
658 |
562 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
494 |
457 |
$1K |
| 80061 |
Lipid panel |
446 |
421 |
$889.03 |
| 86850 |
|
56 |
51 |
$810.63 |
| 36415 |
Collection of venous blood by venipuncture |
528 |
489 |
$780.49 |
| J1756 |
Injection, iron sucrose, 1 mg |
28 |
12 |
$748.00 |
| 86900 |
|
56 |
50 |
$677.35 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
29 |
24 |
$537.00 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
16 |
12 |
$534.24 |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
53 |
49 |
$511.49 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
28 |
25 |
$503.04 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
389 |
363 |
$491.70 |
| 85027 |
|
118 |
111 |
$489.44 |
| 96417 |
|
26 |
12 |
$482.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
16 |
12 |
$411.48 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
372 |
341 |
$402.32 |
| 94010 |
|
53 |
51 |
$327.74 |
| 86901 |
|
56 |
50 |
$321.41 |
| 82077 |
|
71 |
65 |
$244.27 |
| 87077 |
|
82 |
69 |
$239.43 |
| 86803 |
|
55 |
51 |
$239.00 |
| 86696 |
|
50 |
46 |
$231.22 |
| 83615 |
|
245 |
209 |
$207.49 |
| 86780 |
|
53 |
49 |
$199.47 |
| 82043 |
|
201 |
189 |
$167.70 |
| 86695 |
|
50 |
46 |
$167.22 |
| 94618 |
|
13 |
13 |
$157.63 |
| 87040 |
|
16 |
13 |
$149.12 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,281 |
4,949 |
$147.74 |
| 82947 |
|
18 |
16 |
$141.28 |
| 86787 |
|
17 |
15 |
$131.11 |
| 87340 |
|
41 |
38 |
$129.56 |
| 82247 |
|
31 |
25 |
$124.43 |
| 82607 |
|
46 |
40 |
$119.90 |
| 86762 |
|
37 |
35 |
$119.07 |
| 82550 |
|
16 |
16 |
$92.15 |
| 82746 |
|
28 |
27 |
$90.81 |
| 85730 |
|
14 |
12 |
$85.40 |
| 85014 |
|
25 |
25 |
$76.80 |
| 83880 |
|
30 |
26 |
$70.68 |
| 82248 |
|
14 |
12 |
$63.88 |
| 94727 |
|
12 |
12 |
$61.85 |
| 73630 |
|
14 |
13 |
$57.45 |
| 85610 |
|
14 |
12 |
$56.05 |
| 84439 |
|
34 |
27 |
$51.53 |
| 87581 |
|
16 |
12 |
$45.72 |
| 87486 |
|
16 |
12 |
$45.72 |
| 87541 |
|
16 |
12 |
$45.72 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
16 |
12 |
$45.72 |
| 87641 |
|
16 |
12 |
$45.72 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
48 |
38 |
$43.08 |
| 73610 |
|
26 |
25 |
$38.67 |
| 73130 |
|
14 |
13 |
$37.56 |
| 82525 |
|
12 |
12 |
$34.04 |
| 87070 |
|
13 |
12 |
$24.52 |
| 87205 |
|
13 |
12 |
$11.14 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
963 |
882 |
$10.40 |
| A9270 |
Non-covered item or service |
1,231 |
1,081 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
39 |
39 |
$0.00 |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
54 |
52 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
175 |
168 |
$0.00 |
| 84702 |
|
12 |
12 |
$0.00 |